MedPath

To Know Which supportive management of acute bronchiolitis is better in efficacy among 7% saline and 3% saline used in nebulization.

Phase 4
Conditions
Health Condition 1: J210- Acute bronchiolitis due to respiratory syncytial virusHealth Condition 2: J00-J06- Acute upper respiratory infections
Registration Number
CTRI/2024/05/067292
Lead Sponsor
Aarupadai Veedu Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Hospitalized Infants and young children(6 to 24 months)

2.First episode of respiratory distress associated with wheezing

3.Clinical severity score 0 to 6 (ANNEXURE-1)

Exclusion Criteria

1.History of two or more episodes of respiratory distress in past

2.H/o Pneumonia & Antibiotic use

3.Family history of asthma

4.Critically ill Infants and young children (6 to 24 months) suggesting severe acute

bronchiolitis

5.Associated cardiopulmonary diseases such as congenital heart disease, cystic lung

disease, etc.

6.Preterm birth or history of mechanical ventilation in neonatal period

7.Patients with clinical signs of bacterial infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ebulisation with 7% saline has better efficacy than 3% saline in <br/ ><br>supportive management of acute bronchiolitis.Timepoint: Clinical Severity Score is Calculated every 24 hours till the day of the discharge.
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath